S69K was then used to generate CTL from peripheral blood mononuclear cells of an HLA-A1+ normal donor and an HLA-A1+ NB patient carrying a MYCN-amplified tumor (Sarkar and Nuchtern, 2000). Here, MYCN is linked to neoplasm.